
FDA Grants ‘Breakthrough Status’ to Neuralink’s Blindsight Implant
The U.S. Food and Drug Administration (FDA) has recently awarded “breakthrough device” status to Neuralink’s Blindsight implant, an experimental vision-restoring
Type and hit enter
WhatsApp us
Adding {{itemName}} to cart
Added {{itemName}} to cart